Fluorescence of Catechol Amines and Related Compounds Condensed with Formaldehyde””

Total Page:16

File Type:pdf, Size:1020Kb

Fluorescence of Catechol Amines and Related Compounds Condensed with Formaldehyde”” Brain Research Bulkfin, Vol. 9, pp. xi-xv, 1982. Printed in the U.S.A. Fluorescence of Catechol Amines and Related Compounds Condensed With Formaldehyde”” B. FALCK, N.-A. HILLARP, G. THIEME AND A. TORP Department of Histology, University of Lund, and Department of Pharmacology, University of Giiteborg, Sweden Received for publication August 28, 1961 The noradrenaline cells in the adrenal medulla become a) An amount of the amine hydrochloride corresponding fluorescent when briefly fixed in formalin [6,71, but the na- to 25 mg of base was dissolved in 4.5 ml 0.1 N H,SO, (or ture of the reaction has not been elucidated. Recently HCl). After addition of 0.5 ml 35% formaldehyde the solution Eranko [8] and Falck and Tot-p [lo] found that a very intense was heated at 100°C for 20-30 minutes, then cooled and neu- fluorescence develops in the noradrenaline cells when tralized to about pH 5 with K,C03. freeze-dried sections are exposed to formaldehyde vapour. b) The amine hydrochloride was dissolved in water As a great need exists for highly sensitive histochemical and-where necessary-neutralized to about pH 5 with methods for demonstration of mono-amines--i.a. for lo- K,CO,. Formaldehyde (about pH 6) was added and the solu- calization of the brain catechol amines-it was thought tion heated at 50°C for 20 minutes. worth while to study the reaction between formaldehyde and The reaction mixture was transferred to a cation ex- catechol amines in model systems and to isolate and examine change column (Amberlite XE-64, 22x0.55 cm, equilibrated the reaction products. with 1 M ammonium acetate of pH 6). Elution (5 ml frac- tions) was performed with 0.02 and 0.1 M ammonium acetate (pH 6 and pH 5, respectively) and 0.1 N HCI, and was fol- MATERIAL AND METHODS lowed by determination of the ultraviolet absorption of the Fluorescence microscopy. The amines (usually as hydro- fractions. chlorides) and amine-formaldehyde condensation products The main part of the reaction products from the catechol were dissolved in 1% aqueous solutions of human serum amines (80-90%) was eluted in a single peak with the 0.1 M albumin, gelatin, gliadin (wheat), or sucrose. One microliter buffer. The ultraviolet absorption and the fluorescence spots were placed on object glasses and dried at room tem- spectra of the fractions (at pH 2, 5, and 6.5) were taken, and perature or at 50°C. After microscopy the spots were treated spots containing 0.02-l pg of the compounds in 1% serum with the vapour from a 35% solution of formaldehyde (Merck albumin were examined in the fluorescence microscope as p.a.) for varying periods of time either at room temperature described above. Finally the main fractions were pooled and or at 50°C. In the latter case the glasses were prewarmed at evaporated to a small volume in vacua at 40°C (rotating 50°C to prevent water condensation on the spots. evaporator), dissolved in water, and stored at -30°C. The light from an Osram XBO 2001 high-pressure xenon No unchanged catechol amines were found on paper lamp was passed through a water-cooled 1 mm Schott BG 38 chromatography or on spectrophotofluorimetric examina- filter (for heat absorption) and then through a Zeiss M4 QII tions according to Carlsson and Waldeck [4], or Bertler, monochromator whose exit slit was projected in the dia- Carlsson and Rosengren [2]. phragm of the condenser of a fluorescence microscope. To Preparation of I-methyl-6,7-dihydroxy-I ,2,3,4-tetra- prevent stray light in the visible region from the mono- hydroisoquinoline. Dopamine was condensed with acetal- chromator reaching the microscope a suitable filter (usually a dehyde according to the procedure of Kovacs and Fodor 2 mm Schott BG 12) was placed before the condenser. Ex- [17], which gives a good yield of the tetrahydroisoquinoline. changeable stop filters were placed in the microscope tube The substance was crystallized twice from alcohol-ether. No (usually a Schott GG 4 and above it a Wratten gelatin filter unchanged dopamine was found on paper chromatography. No. 15). Paper chromatography. The amine-formaldehyde prod- Preparation of amine-formaldehyde condensation prod- ucts were examined by ascending paper chromatography ucts. Dopamine, noradrenaline, and adrenaline were treated using n-butanol-glacial acetic acid-water (4:1:5) as the with an excess of formaldehyde either in acid or at pH about 5. solvent system. After drying, the papers were examined in ‘Supported by grants from the Swedish Medical Research Council, the Air Force Ofice of Scientific Research and Development Command, United States Air Force, and by a grant (B-2854) from the National Institutes of Health. *Reprinted with permission from The Journal of Histochemistry and Cytochemistry, Vol. 10, No. 3, May, 1962, Copyright a 1962 by The Williams & Wilkins Co. xi \il FALCK. HILLARP, THIEME AND TORP TABLE 1 TABLE 2 FLUORESCENCE OF CATECHOL AMINES AND RELATED COMPARISON OF FLUORESCENCE INTENSITIES DEVELOPED COMPOUNDS INCLUDED IN A DRIED SERUM ALBUMIN FILM FROM CATECHOL AMINES AND SOME RELATED COMPOUNDS AFTER TREATMENT WITH FORMALDEHYDE VAPOUR AT INCLUDED IN A DRIED SERUM ALBUMIN FILM EXPOSED TO ~50°CFOR I5 MINUTES FORMALDEHYDE VAPOUR AT 50°C FOR 5 OR 15 MINUTES Amount Fluorescence 5 Min IS Min 0.2 0.02 0.01 0.2 0.02 0.01 Phenylalanine @“I: Fc! Tyrosine Meta-tyrosine + 0 0 2t 0 0 Meta-tyrosine Dopa 5+ 3t 2-t 6-c 4+ i- Dopa (3,4-dihydroxy-phenyl- a-methyl-dopa t 0 0 ? 4 0 0 alanine) 0.2 6+ Meta-tyramine 3-t 0 0 4t i 0 a-Methyl-dopa 1 4+ Dopamine 57 3- ?* 6- 4-r 72 Ij-Phenylethylamine 1 0 Noradrenaline 5+ 3t 21 61 4- 3+ Tyramine (Chydroxy-phenyl- Adrenaline 0 0 0 + 0 0 ethylamine) I 0 Epinine 0 0 0 i 0 0 Meta-tyramine (3-hydroxy- Methoxy- phenylethylamine) 0.2 4+ tyramine 0 0 0 + 0 0 Octopamine (4-hydroxy-phenyl ethanolamine) I 0 Dopamine (3,4-dihydroxy- phenylethylamine) 0.2 6+ Noradrenaline 0.2 6+ Adrenaline I 3+ 15 minutes. An exposure at this temperature for a longer Methoxy-tyramine (3-methoxy- time usually weakened or even destroyed the fluorescence. 4-hydroxy-phenylethylamine) I 31 but at about 20°C an exposure time of up to 24 hours could be Normetanephrine (3-methoxy-4- used. hydroxy-phenylethanolamine) I 0 As seen from Tables I and 2 there are certain structural Phenylephrine (3-hydroxy-N- requirements for the fluorescence reaction. Of the methyl-phenylethanolamine) I + phenylalanine and phenylethylamine derivatives used, a Epinine (3,4-dihydroxy-N- very intense fluorescence is given only by those that are methyl-phenylethylamine) I 3+ primary amines and also have hydroxyl groups at the 3 and 4 Hordenine (4-hydroxy-N,N- positions (dopa, dopamine, noradrenaline). An interesting dimethyl-phenylethylamine) I 0 exception is cw-methyl-dopa (see Discussion). The catechol 3.4-Dihydroxyphenylacetic acid I 0 amines, which are secondary amines (adrenaline and epinine), give a much weaker fluorescence, which further- more develops more slowly in the formaldehyde treatment. Thus it is possible to distinguish between noradrenaline and adrenaline in sections of adrenal medulla by means of the formaldehyde reaction [8,10]. Some data illustrating the ultraviolet light and then sprayed with K,Fe (CN), according sensitivity and the rate of the reaction are found in Table 2. to James [16]. The results obtained favour the view that the 3-OH group Fluorimetry. The fluorescence spectra of the amines and is essential for the fluorescence reaction. Thus the com- their formaldehyde condensation products (l-10 pg/ml), be- pounds with no hydroxyl group or only one in the position fore and after oxidation with HzO, according to Hess and pura to the side chain seem to be non-reactive, whereas the Udenfriend [15], were determined at various pHs with the meta isomers of tyrosine and tyramine show a fairly Aminco-Bowman spectrophotofluorometer. The wave- pronounced fluorescence. Furthermore the substitution of lengths given for activation and fluorescence are the uncor- the 3-OH group by a methoxy group in dopamine and norad- rected instrument values. renaline dramatically inhibits the reaction. The fluorescent products formed from the primary amines in dried spots of serum albumin were quite stable for days at RESULTS room temperature. The fluorescence did not disappear if the Fluorrswnce of amines in model systems: The catechol spots were furth&r dried in vac’uo over P20:, (2 days) or by amines and related compounds examined (see Table 1) heating at 150°C (1 hour). No material decrease of the showed no visible fluorescence in dried spots containing 1 pg fluorescence was found after extraction of the spots with of the substances in serum albumin. After exposure of the water, 0.1 N HCl, ethyl alcohol, xylene, or benzene, or at spots to formaldehyde vapour some of them were trans- acid hydolysis (0.1 N HCl, lOO”C, 10 min). formed into products which fluoresced intensely green to The amines were also examined enclosed in dried spots of yellow. The activation peak lies at 420-440 mp. Serum al- gelatin, gliadin, or sucrose. The fluorescence obtained in bumin itself-after treatment with formaldehyde-showed a gelatin was of somewhat lower intensity, and in gliadin or very faint dirty-green fluorescence. sucrose much weaker than that developed in serum albumin. In most instances a maximum fluorescence was obtained The products formed in gelatin, and especially in gliadin, when the formaldehyde treatment was performed at 50°C for were also to a higher extent extractable with water.
Recommended publications
  • Tyler's Herbs of Choice: the Therapeutic Use of Phytomedicinals Category
    Tyler’s Herbs of Choice The Therapeutic Use of Phytomedicinals Third Edition © 2009 by Taylor & Francis Group, LLC Tyler’s Herbs of Choice The Therapeutic Use of Phytomedicinals Third Edition Dennis V.C. Awang Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business © 2009 by Taylor & Francis Group, LLC CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2009 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-0-7890-2809-9 (Hardcover) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher can- not assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • Learning Objectives
    2/26/2019 To help ensure the integrity of competition for Dirty Dozen: High Risk athletes, sports organizations and fans Sport Supplement worldwide. Ingredients Lara Gray, MS, RD, CSSD Senior Director of Education, Board Certified Sports Dietitian 1 Welcome! Learning Objectives Things to note: At the end of the presentation, attendees will 1. It is required by the BOC for Certified Athletic Trainers that you are actively be better able to: present in the live event AND complete the post-webinar survey in order to • Identify dietary ingredients that pose a threat to drug tested athletes. receive your CEU certificate. • Explain how high risk dietary ingredients are being used in sports 2. CEU Statements of Credit (if applicable) supplements. will be emailed to attendees no later than Friday, March 1st. • Analyze sports supplements for high risk dietary ingredients. 3. Please use the “Questions” box in GoToWebinar. Questions will be reviewed by the moderator and answered at the Drug Free Sport International (BOC AP# P8729) is approved by the Board of Certification, Inc. to end. provide continuing education to Athletic Trainers. This program is eligible for a maximum of 1 Category A hour/CEU. ATs should claim only those hours actually spent in the educational program. 4. Download today’s handouts from the “Handouts” tab. 1 2/26/2019 Today: An In-Depth Look 40% - 100% ATHLETES USE SUPPLEMENTS • Type of sport • Level of competition • Definition of supplements Garthe, Ina, and Ronald J. Maughan. "Athletes and Supplements: Prevalence and Perspectives." International journal of sport nutrition and exercise metabolism 28.2 (2018): 126‐138.
    [Show full text]
  • Thomas A. Ban: Neuropsychopharmacology in Historical Perspective Collated 25
    Thomas A. Ban: Neuropsychopharmacology in Historical Perspective Collated 25 Joseph Knoll: The Discovery of the Enhancer Regulation in the Mammalian Brain and the Development of the Synthetic Enhancer Substances Knoll February 4, 2016 Review Warnes May 19, 2016 Comment Knoll February 16, 2017 Reply 1 to Warnes comment Knoll July 14, 2016 Reply 2 to Warnes´ comment Warnes August 24, 2017 Response 1 to Knoll’s replies (1 & 2) Knoll October 19, 2017 Response 1 to Warnes’ response 1 Warnes January 4, 2018 Response 2 to Knoll’s response 1 Knoll January 25, 2018 Response 2 to Warnes’ response 2 Warnes April 26, 2018 Response 3 to Knoll’s response 2 Knoll May 3, 2018 Additional response 2 to Warnes’ response 2 Warnes August 30, 2018 Final response 4 to Knoll’s additional response 2 Joseph Knoll: The Discovery of the Enhancer Regulation in the Mammalian Brain and the Development of the Synthetic Enhancer Substances A chance to significantly improve the quality and prolong the duration of human life 2 Content Introduction PART 1 Indications of the key role of (-) deprenyl (DEP) in the discovery of the enhancer regulation in the mammalian 1.1 The origin of the “enhancer-regulation” concept 1.2. Development of (-)-deprenyl (DEP) the first selective inhibitor of B-type monoamine oxidase (MAO-B) and the first catecholaminergic activity enhancer (CAE) substance 1.3. Congruous data conforming to the concept that quality and duration of mammalian life rests primarily upon the inborn efficiency of the catecholaminergic neurons, “the engine of the brain” 1.4. Positive proof by DEP that a catecholaminergic activity enhancer (CAE) regulation works in the catecholaminergic neuron 1.5.
    [Show full text]
  • The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats
    W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 4-2017 The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats Justin P. Canakis College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the Animal Sciences Commons, Exercise Science Commons, Laboratory and Basic Science Research Commons, and the Other Nutrition Commons Recommended Citation Canakis, Justin P., "The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats" (2017). Undergraduate Honors Theses. Paper 1128. https://scholarworks.wm.edu/honorstheses/1128 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. 1 2 Title Page……………………………………………………………………………………...…..1 Abstract…………………………………………………………………………………………....5 Acknowledgement……………………………………………………………………….………..6 Background.………………………………………………………………………..……………...7 DSEHA and its Effect on the VMS Industry………………...……………………………7 History of Adverse Side Effects from Pre-Workout Supplements ………….……………8 Ingredient Analysis ………………………………………..……………….……………..……....9 2.5g Beta-Alanine…………………………..……………………………………………..9 1g Creatine Nitrate……………………………...……………………………………..…12 500mg L-Leucine……………………………………………………………………...…16 500mg Agmatine Sulfate……………………….………………………………..………18
    [Show full text]
  • Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected]
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 4-25-2018 Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected] DOI: 10.25148/etd.FIDC006565 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Chemistry Commons Recommended Citation Seither, Joshua Zolton, "Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances" (2018). FIU Electronic Theses and Dissertations. 3823. https://digitalcommons.fiu.edu/etd/3823 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY FOR THE SCREENING AND CONFIRMATION OF NOVEL PSYCHOACTIVE SUBSTANCES A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in CHEMISTRY by Joshua Zolton Seither 2018 To: Dean Michael R. Heithaus College of Arts, Sciences and Education This dissertation, written by Joshua Zolton Seither, and entitled Application of High- Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Piero Gardinali _______________________________________ Bruce McCord _______________________________________ DeEtta Mills _______________________________________ Stanislaw Wnuk _______________________________________ Anthony DeCaprio, Major Professor Date of Defense: April 25, 2018 The dissertation of Joshua Zolton Seither is approved.
    [Show full text]
  • Amphetamine-Like Compounds in Pre-Workout Supplements
    Bond University MASTER'S THESIS Amphetamine-like compounds in pre-workout supplements Koh, Andy Award date: 2017 Link to publication General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 10. May. 2019 Amphetamine-like Compounds in Pre-Workout Supplements By Andy Hsien Wei Koh Submitted in total fulfilment of requirements of the degree of Masters of Science by Research (Health Sciences) January 2017 Faculty of Health Sciences and Medicine Bond University, Queensland, Australia Assistant Professor Anna Lohning and Professor Russ Chess-Williams Thesis Summary Pre-workout supplements (PWS), like most nutritional supplements, are classified by the Therapeutic Goods Administration (TGA) in Australia as complementary medicines and are therefore subject to much less stringent regulation compared to pharmaceuticals. Complementary medicines (also known as 'traditional' or 'alternative' medicines) include vitamin, mineral, herbal, aromatherapy and homoeopathic products. PWS comprise a group of sports supplements purported to provide consumers with a boost in athletic performance facilitated by the inclusion of stimulatory compounds usually of plant origin.
    [Show full text]
  • Case Study. Wastewater to Monitor New Psychoactive Substances
    Wastewater to monitor new psychoactive substances Dr David M Wood Consultant Physician and Clinical Toxicologist Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK COST is supported by the ESF provides the EU Framework COST Office through Programme Horizon 2020 an EC contract Epidemiology of drug use Population Sub-population Self-Reported Use Variable content of drugs ‘Ecstasy’ Variable content of drugs Novel Drugs Could we samples from portable urinals? . Portable urinals widely used in city centres across Europe . Self-collecting or direct sewer emptying . Self-collecting systems - Urine discarded when urinals picked up - Potential to collect this discarded urine for analysis - Take sampling closer to point of elimination Could we samples from portable urinals? . Participation anonymous and voluntary . Individuals can use study urinals or standard toilets . Not a true (sub) population sample – Males “only” Approvals process . London Metropolitan Police permission . Discussed with Ethics Committee – Formal ethical approval not required . UK Human Tissue Act exempt Archer JR, Wood DM, Hudson S, Dargan PI. Current Drug Abuse Reviews 2013 In Press Studies from our network since 2011 . July 2011: – Urinal in South East London nightclub July 2011 . March 2012 onwards: – 12x urinals in central London . July 2012 onwards: – Urinal in North West England music festival . December 2012: – Urinal at an Oslo, Norway music festival . April 2014: – Pan-London urinal study Archer JR JSU 2012; Archer JR CLin Tox 2012, Archer JR QJM 2013; Dargan PI Clin Tox 2012; Wood DM Clin Tox 2013; Archer JR Clin Tox 2013; Heyerdal F Clin Tox 2013 City Centre Studies Urinal Pilot Study – Summer 2011 Sampling site .
    [Show full text]
  • World of Cognitive Enhancers
    ORIGINAL RESEARCH published: 11 September 2020 doi: 10.3389/fpsyt.2020.546796 The Psychonauts’ World of Cognitive Enhancers Flavia Napoletano 1,2, Fabrizio Schifano 2*, John Martin Corkery 2, Amira Guirguis 2,3, Davide Arillotta 2,4, Caroline Zangani 2,5 and Alessandro Vento 6,7,8 1 Department of Mental Health, Homerton University Hospital, East London Foundation Trust, London, United Kingdom, 2 Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3 Swansea University Medical School, Institute of Life Sciences 2, Swansea University, Swansea, United Kingdom, 4 Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy, 5 Department of Health Sciences, University of Milan, Milan, Italy, 6 Department of Mental Health, Addictions’ Observatory (ODDPSS), Rome, Italy, 7 Department of Mental Health, Guglielmo Marconi” University, Rome, Italy, 8 Department of Mental Health, ASL Roma 2, Rome, Italy Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. While treating cognitive deficit symptoms in neuropsychiatric or neurodegenerative disorders using CEs might have significant benefits for patients, the increasing recreational use of these substances by healthy individuals raises many clinical, medico-legal, and ethical issues. Moreover, it has become very challenging for clinicians to Edited by: keep up-to-date with CEs currently available as comprehensive official lists do not exist. Simona Pichini, Methods: Using a web crawler (NPSfinder®), the present study aimed at assessing National Institute of Health (ISS), Italy Reviewed by: psychonaut fora/platforms to better understand the online situation regarding CEs.
    [Show full text]
  • Tyler's Herbs of Choice: the Therapeutic Use of Phytomedicinals Category
    Tyler’s Herbs of Choice The Therapeutic Use of Phytomedicinals Third Edition © 2009 by Taylor & Francis Group, LLC Tyler’s Herbs of Choice The Therapeutic Use of Phytomedicinals Third Edition Dennis V.C. Awang Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business © 2009 by Taylor & Francis Group, LLC CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2009 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-0-7890-2809-9 (Hardcover) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher can- not assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers.
    [Show full text]
  • Journal of the International Society of Sports Nutrition Biomed Central
    Journal of the International Society of Sports Nutrition BioMed Central Research article Open Access The acute effects of the thermogenic supplement Meltdown on energy expenditure, fat oxidation, and hemodynamic responses in young, healthy males Jean Jitomir1, Erika Nassar1, Julie Culbertson3, Jen Moreillon1, Thomas Buford1, Geoffrey Hudson1, Matt Cooke1, Richard Kreider3 and Darryn S Willoughby*1,2 Address: 1Department of Health, Human Performance, and Recreation, Baylor University, Box 97313, Waco, TX 76798, USA, 2Institute for Biomedical Science, Baylor University, Waco, TX 87898, USA and 3Department of Health and Kinesiology, Texas A&M University, College Station, TX 78743, USA Email: Jean Jitomir - [email protected]; Erika Nassar - [email protected]; Julie Culbertson - [email protected]; Jen Moreillon - [email protected]; Thomas Buford - [email protected]; Geoffrey Hudson - [email protected]; Matt Cooke - [email protected]; Richard Kreider - [email protected]; Darryn S Willoughby* - [email protected] * Corresponding author Published: 16 December 2008 Received: 5 November 2008 Accepted: 16 December 2008 Journal of the International Society of Sports Nutrition 2008, 5:23 doi:10.1186/1550-2783-5-23 This article is available from: http://www.jissn.com/content/5/1/23 © 2008 Jitomir et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract The purpose of this study was to evaluate the effects of a thermogenic supplement, Meltdown, on energy expenditure, fat oxidation, and hemodynamics before and after maximal treadmill exercise.
    [Show full text]
  • Stimulant Analytical Standards
    Stimulant Analytical Standards Stimulants belong to a diverse group of psychoactive drugs whose function exerts a constant contribution to hyperactivity and impulse control. Illegal stimulant derivatives including amphetamines, arylcyclohexylamines, cathinones, cocaine/tropanes, phenethylamines, and piperazines are among the most widely abused across the US and Europe. However, the popularity of each substance, particularly in party culture settings, is frequently changing. Cayman offers more than 700 analytical standards for the identification of stimulants and is dedicated to working with the forensic community to quickly make reference standards available for new psychoactive substances (NPS). A library of mass spectral data containing many of Cayman’s emerging stimulant standards is freely available for download at www.caymanchem.com/CSL. More than 700 Stimulant Standards Available for · Amphetamines · Indanes · Arylcyclohexylamines · Phenethylamines · Cathinones · Piperazines · Cocaine & Tropanes · And More Tools to Rapidly Screen for Major Controlled Stimulants Cocaine/Heroin/Methamphetamine Mixture (CRM) Item No. 9002662 A CRM mixture of cocaine, heroin, and methamphetamine (1 mg/ml of each) GC-MS Drug Standard Mixture 4 Item No. 24632 A mixture of common stimulants, opioids, and Representative chromatogram of the compounds steroids as well as a synthetic cannabinoid and a included in the GC-MS Drug Standard Mixture 4 benzodiazepine (250 μg/ml of each) Peak order from left to right: α-Pyrrolidinobutiophenone, α-Pyrrolidinopentiophenone,
    [Show full text]